P&G may trim headcount
This article was originally published in The Tan Sheet
Executive SummaryProcter & Gamble plans to maintain or slightly decrease current staffing levels in the foreseeable future to promote cost-savings, Chairman and CEO A.G. Lafley reports during a Feb. 21 presentation at the Consumer Analysts Group of New York Conference. "We're cutting the number of expats in half and reducing staffing by 15 percent at the general manager level and above," Lafley notes. "This will reduce the average cost-per-person." Additionally, the company continues to reduce distribution centers globally and aims to eliminate duplication between organizations, with the goal of eliminating 10 percent to 20 percent of initiative development effort among teams...
You may also be interested in...
CMR Surgical’s Versius robotic system is now live in the UK NHS, the company announced 20 February.
Despite seeing an 8% drop in global turnover in 2019, an upbeat Teva says the completion of its restructuring plan has positioned the company to increase its turnover through newly-launched products – including biosimilars, brands and new generics – as well as improve its profit margins through manufacturing optimization.
Japanese big pharma Eisai taps Celgene and Sanofi execs as its new VPs for corporate affairs and market access. And Freeline Therapeutics, developer of gene therapies for bleeding disorders, selects a former Alnylam Pharma SVP as CEO.